The regulator said the guidance reflects a broader push to accelerate the development of highly personalised therapies while maintaining rigorous scientific oversight. …
FDA moves to strengthen safety standards for genome editing therapies
April 15, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Mark Butler confirms new and expanded cancer medicine listings
April 17, 2026 - - Latest News -
Why hospitals, and not medicines, dominate America’s health spending gap
April 17, 2026 - - Latest News -
Australia, the US, and their different choices about health system trade-offs
April 17, 2026 - - Latest News -
New strategic alliance for Biointelect aims to fast track life sciences innovation
April 17, 2026 - - Latest News -
Why US health spending looks much higher than it really is
April 16, 2026 - - Latest News -
Pharmacy prescribing reform signals shift in NSW primary care with Victoria to follow
April 15, 2026 - - Latest News -
Noxopharm appoints Dr Olivier Laczka as CEO to lead next phase of growth
April 15, 2026 - - Australian Biotech